[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Biotricity and B-Secur Target the Consumer Wearables Market with Expansion of Next-Gen Cardiac Monitoring Platform

Biotricity Black.png

Biotricity , an innovative medical technology company specializing in remote cardiac monitoring solutions, and B-Secur, a leader in ECG algorithm and biosensing technology, are transforming the consumer wearables market with an enhancement to their joint cardiac monitoring platform.

The device-neutral platform, which launched in early 2025 for ambulatory cardiac monitoring, will now support ECG data from consumer wearables. This advancement enables the seamless integration and review of user data collected from smartwatches, smart rings, fitness trackers, and other mobile health products within Biotricity’s cloud-based medical workflow.

The move solidifies Biotricity and B-Secur’s leadership in digital cardiovascular innovation, positioning the companies at the forefront of the rapidly expanding heart health market.

Also Read: AiThority Interview with Dr. Petar Tsankov, CEO and Co-Founder at LatticeFlow AI

Related Posts
1 of 41,527

“Biotricity’s mission has been to make high-quality cardiac care accessible to everyone,” explained Dr. Waqaas Al-Siddiq, founder and CEO of Biotricity. “Through our strategic collaboration with B-Secur, we’re introducing clinical-grade heart monitoring to consumer wearables, providing patients and their healthcare providers with the tools they need to understand and manage heart health like never before.”

Leveraging B-Secur’s FDA-cleared HeartKey® ECG algorithms and advanced analytics, the platform delivers medical-grade accuracy trusted by healthcare professionals. Its device-agnostic design and cloud-enabled infrastructure allow developers and OEMs to seamlessly integrate data from smart devices into regulated care pathways, efficiently bridging the gap between consumer devices and clinical care.

“This advancement addresses the growing global demand for preventive cardiovascular solutions in younger and aging populations,” said Tyeler Dean, VP of Medical at B-Secur. “It enables scalable, user-friendly health tech while maintaining the same level of clinical-grade accuracy trusted by healthcare professionals and increasingly expected by consumers.”

Also Read: Developing Autonomous Security Agents Using Computer Vision and Generative AI

[To share your insights with us as part of editorial or sponsored content, please write to psen@itechseries.com]

Comments are closed.